VWF release and platelet aggregation in human melanoma after perfusion with TNFα

Keyphrases

• Von Willebrand Factor 100%
• Perfusion 100%
• Platelet Aggregation 100%
• Human Melanoma 100%
• Thrombocyte Aggregation 40%
• Thrombocytes 40%
• Tissue Factor 40%
• Interferon-α (IFN-α) 20%
• Melphalan 20%
• Endothelium 20%
• Morphological Changes 20%
• Tumor Necrosis Factor-α 20%
• Tumor Vasculature 20%
• High Dose 20%
• Adhesion 20%
• Necrosis 20%
• CD41 20%
• Immunostaining 20%
• α-smooth muscle Actin (α-SMA) 20%
• Melanoma Patients 20%
• Blood Flow 20%
• Isolated Limb Perfusion 20%
• Edema 20%
• Vascular Damage 20%
• Hemorrhagic Infarction 20%
• Fibrin 20%
• Recombinant Human Tumor Necrosis Factor 20%
• Type IV Collagen 20%
• Congestion 20%
• Sequential Biopsy 20%
• Static Image 20%
• Triple Therapy 20%
• Microvascular Changes 20%
• Vascular Hemostasis 20%
• Procoagulant Activity 20%
• Endothelial Cell Damage 20%
• Induced Endothelial Cells 20%
• Fibrin Deposit 20%
• Subepidermal 20%
• Fibrin Thrombi 20%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Thrombocyte Aggregation 100%
• Von Willebrand Factor 100%
• Melanoma 100%
• Platelet 40%
• Biopsy Technique 40%
• Thromboplastin 40%
• Immunohistochemistry 20%
• Combination Therapy 20%
• Morphology 20%
• Endothelial Cell 20%
• Tumor Vascularization 20%
• Melphalan 20%
• Drug Megadose 20%
• Necrosis 20%
• Blood Vessel Injury 20%
• Bleeding 20%
• Smooth Muscle Actin 20%
• Collagen Type 4 20%
• Infarction 20%
• Cell Damage 20%
• Blood Flow 20%
• Interferon Alfa 20%
• Limb Perfusion 20%
• Edema 20%
• Tumor Necrosis 20%
• Fibrin Clot 20%
• Blood Stasis 20%
• Procoagulant 20%
• Subendothelium 20%

Immunology and Microbiology

• Thromboplastin 66%